The chairman of Australian Clinical Labs has waded into a dispute between Healius and its rival’s major investor, John Wylie’s Tanarra Capital, accusing the latter of not disclosing its relationship with one of the company’s non-executive directors which the investment group is supporting.
Michael Alscher, in a letter to Healius chairman Jenny Macdonald sent late on Thursday and obtained by AFR Weekend, says Tanarra has not disclosed Michael Stanford’s “previous engagement” with Mr Wylie.
Loading...
Simon Evans writes on business specialising in retail, manufacturing, beverages, mining and M&A. He is based in Adelaide. Connect with Simon on Twitter. Email Simon at simon.evans@afr.com
